Skip to Content Skip to Main Navigation Skip to Local Navigation Skip to Search

dantrolene sodium hemiheptahydrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
DANTRIUM dantrolene sodium hemiheptahydrate 25mg capsule bottle
AUST R: 42975
Active ingredients:
dantrolene sodium hemiheptahydrate

Dosage form:
Capsule

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

From
28 May 2018
to
31 Dec 2023

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.
DANTRIUM dantrolene sodium hemiheptahydrate 20mg powder for injection vial
AUST R: 14435
Active ingredients:
dantrolene sodium hemiheptahydrate

Dosage form:
Injection, powder for

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

From
04 Nov 2022
to
14 Mar 2023

Shortage status:
Resolved

Availability:
Available

Reason:
Unexpected increase in consumer demand